Sin conexión a internet: se muestra la versión guardada de la página.

Jasper Therapeuti…

USUSD
← Al screener

Jasper Therapeutics, Inc. (US:JSPR) — Biotechnology: Biological Products (No Diagnostic Substances). Número de bolsas en las que cotizan las acciones de la empresa: 1. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la empresa

Sitio web
jaspertx.com
Sector
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Sede central
REDWOOD CITY, United States
Acciones en circulación
33.27 M a 2026-08-10
Capitalización bursátil
20.83 M USD
Insiders
2.87%
Inversores institucionales
39.43%
Industria (SIC)
Biological Products, (No Diagnostic Substances)
Descripción

Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is based in Redwood City, California.

Bolsas y tickers

BolsaTickerMonedaPrecioTipo
US USA StocksJSPRUSD0.56 -1.70%acciones ordinarias

Precio en 3 meses

US:JSPR · USD
día alcista día bajista fecha ex-dividendo fecha de pagoPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Dividendos

No se han encontrado pagos de dividendos (comprobado el 09.10.2026). Es probable que la empresa no reparta dividendos.

Noticias de esta semana

Aún no hay noticias del sitio web de la empresa.

anuncio

Principales accionistas

TitularParticipaciónAccionesFecha del informe
Velan Capital Investment…16.04%5.34 M2026-06-30
Acorn Capital Advisors,…8.64%2.88 M2026-06-30
Kingdon Capital Manageme…8.13%2.7 M2026-06-30
Vanguard Capital Managem…7.04%2.34 M2026-06-30
Rock Springs Capital Man…6.62%2.2 M2026-06-30
Carlyle Group Inc.6.41%2.13 M2026-06-30
VANGUARD INDEX FUNDS-Van…5.01%1.67 M2026-06-30
GSA Capital Partners LLP3.21%1.07 M2026-06-30
Millennium Management Ll…2.93%973 8662026-06-30
Lion Point Capital, LP2.79%930 0002026-06-30
VANGUARD INDEX FUNDS-Van…1.88%624 0642026-06-30
Geode Capital Management…1.59%527 6162026-06-30
SHIZURU JUDITH ANNE M.D.…≈0.47%156 9012025-09-22
Fidelity Concord Street…0.38%127 5252026-07-31
MARTELL RONALD A (Chief…≈0.22%74 1182025-09-22
VANGUARD VALLEY FORGE FU…0.16%53 1962026-06-30
Fidelity Concord Street…0.15%49 8962026-07-31
Fidelity Concord Street…0.1%34 1092026-07-31
MAHAL JEETINDER SINGH (C…≈0.08%25 0092024-12-12
LUCAS SVETLANA (Director…≈0.06%20 0002025-09-22
ADVISORS' INNER CIRCLE I…0%2922026-04-30
WIGGANS THOMAS G (Direct…——2025-09-22